(Q28373208)

English

Oxazolidinones: a review

scientific article

Oxazolidinones

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10718097%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

Europe PubMed Central

Oxazolidinones: a review (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10718097%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

0 references

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10718097%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10718097%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

59

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10718097%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10718097%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

7-16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10718097%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a.

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059010-00002

21 January 2018

Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200059010-00002

21 January 2018

QUANTITATIVE ACTION OF PENICILLIN INHIBITOR FROM PENICILLIN-RESISTANT STRAINS OF STAPHYLOCOCCI.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bacteremia due to viridans streptococci in neutropenic patients: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disk diffusion test interpretive criteria and quality control recommendations for testing linezolid (U-100766) and eperezolid (U-100592) with commercially prepared reagents

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activities of the oxazolidinone antibiotics U-100592 and U-100766 against Staphylococcus aureus and coagulase-negative Staphylococcus species

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro antibiotic synergy against Flavobacterium meningosepticum: implications for therapeutic options

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ribosomes from an oxazolidinone-resistant mutant confer resistance to eperezolid in a Staphylococcus aureus cell-free transcription-translation assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity and spectrum of LY333328, a novel glycopeptide derivative.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of linezolid and eperezolid, two novel oxazolidinone antimicrobial agents, against anaerobic bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxazolidinones: new antibacterial agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vancomycin-resistant enterococci

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, an

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel antimicrobial agent joins the battle against resistant bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Daptomycin disrupts membrane potential in growing Staphylococcus aureus

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxazolidinones, a new class of synthetic antituberculosis agent in vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro activity of oxazolidinones against Mycobacterium avium Complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emergence of vancomycin resistance in coagulase-negative staphylococci

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibilities of Legionella spp. to newer antimicrobials in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997).

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative in vitro and bactericidal activity of oxazolidinone antibiotics against multidrug-resistant enterococci

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE program

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activities in new oxazolidinone antimicrobial agents against enterococci

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Update: Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activities of an investigational quinolone, glycylcycline, glycopeptide, streptogramin, and oxazolidinone tested alone and in combinations against vancomycin-resistant Enterococcus faecium

1 reference

https://pubmed.ncbi.nlm.nih.gov/10718097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28373208&oldid=2177632436"